{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:49:10Z","timestamp":1792169350289,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jid.2026.09.859","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:55Z","timestamp":1792166575000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitiligo-associated variants and genes beyond immune-related loci: A genome-wide association and Mendelian randomization meta-analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9965-755X","authenticated-orcid":false,"given":"David","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3347-0629","authenticated-orcid":false,"given":"Bryan L.","family":"Peacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-9369","authenticated-orcid":false,"given":"Jonathan C.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3387-461X","authenticated-orcid":false,"given":"Liana N.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-7607","authenticated-orcid":false,"given":"Christy","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9754-9688","authenticated-orcid":false,"given":"Kai","family":"Gravel-Pucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3208-6446","authenticated-orcid":false,"given":"Brian R.","family":"Ferolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-7076","authenticated-orcid":false,"given":"Kelly","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-5971","authenticated-orcid":false,"given":"Lee E.","family":"Wheless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-9100","authenticated-orcid":false,"given":"Rebecca I.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.09.859_bib1","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200277","article-title":"Aldh2 is a lineage-specific metabolic gatekeeper in melanocyte stem cells","volume":"149","author":"Brunsdon","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.jid.2026.09.859_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jid.2026.09.859_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.09.859_bib4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jamadermatol.2025.3512","article-title":"Validating the use of ICD-10 codes for identifying vitiligo","volume":"161","author":"Cheng","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.09.859_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","article-title":"Oxidative stress and mitochondrial dysfunction in glaucoma","volume":"13","author":"Chrysostomou","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jid.2026.09.859_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41592-019-0509-5","article-title":"Assessment of network module identification across complex diseases","volume":"16","author":"Choobdar","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2026.09.859_bib7","unstructured":"DICE (Database of Immune Cell Expression, eQTLs, and Epigenomics). https:\/\/dice-database.org\/. Accessed 2 September 2025."},{"key":"10.1016\/j.jid.2026.09.859_bib8","doi-asserted-by":"crossref","unstructured":"DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. 2018. Targeted therapy and molecular genetics. In: Clinical Gynecologic Oncology. 9th ed. Elsevier:470\u201392.e10. https:\/\/doi.org\/10.1016\/B978-0-323-40067-1.00018-8","DOI":"10.1016\/B978-0-323-40067-1.00018-8"},{"key":"10.1016\/j.jid.2026.09.859_bib9","unstructured":"European Bioinformatics Institute. NHGRI-EBI GWAS Catalog. https:\/\/www.ebi.ac.uk\/gwas\/. Accessed 30 August 2025."},{"key":"10.1016\/j.jid.2026.09.859_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","article-title":"Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors","volume":"207","author":"Faraj","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2026.09.859_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2026.09.859_bib12","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.3390\/jcm10194597","article-title":"Effect of bone morphogenetic protein-2 in the treatment of long bone non-unions","volume":"10","author":"Fuchs","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jid.2026.09.859_bib13","doi-asserted-by":"crossref","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","article-title":"Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics","volume":"49","author":"Ghoussaini","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2026.09.859_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","article-title":"Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jid.2026.09.859_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2026.09.859_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227909","article-title":"The relationship between stress and vitiligo: evaluating perceived stress and electronic medical record data","volume":"15","author":"Henning","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2026.09.859_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00063030-200822030-00004","article-title":"Mecasermin","volume":"22","author":"Keating","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.jid.2026.09.859_bib18","first-page":"1800","article-title":"MEI4 \u2013 a central player in the regulation of meiotic DNA double-strand break formation in the mouse","volume":"128","author":"Kumar","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jid.2026.09.859_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jid.2026.09.859_bib20","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2026.09.859_bib21","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-21-0611","article-title":"Vorasidenib, a dual inhibitor of mutant IDH1\/2, in recurrent or progressive glioma; results of a first-in-human phase I trial","volume":"27","author":"Mellinghoff","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2026.09.859_bib22","unstructured":"National Center for Biotechnology Information. GABBR1 gamma-aminobutyric acid type B receptor subunit 1 [Homo sapiens (human)] gene. https:\/\/www.ncbi.nlm.nih.gov\/gene\/2550. Accessed 29 November 2025."},{"key":"10.1016\/j.jid.2026.09.859_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73557-4","article-title":"Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy","volume":"10","author":"Neumann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2026.09.859_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: A review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.09.859_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamadermatol.2024.0021","article-title":"Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients","volume":"160","author":"Renert-Yuval","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.09.859_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2022.2132628","article-title":"Role of chemical exposure in the incidence of vitiligo: a case-control study in Tunisia","volume":"18","author":"Rmadi","year":"2023","journal-title":"Libyan J Med"},{"key":"10.1016\/j.jid.2026.09.859_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2019.06.013","article-title":"Family clustering of autoimmune vitiligo results principally from polygenic inheritance of common risk alleles","volume":"105","author":"Roberts","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2026.09.859_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pcmr.12848","article-title":"The genetic architecture of vitiligo","volume":"33","author":"Roberts","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"10.1016\/j.jid.2026.09.859_bib29","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1097\/JS9.0000000000002356","article-title":"Toxicological insights and safety considerations of vorasidenib in grade 2 astrocytoma and oligodendroglioma","volume":"111","author":"Silva","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.jid.2026.09.859_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2026.09.859_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The genetic basis of vitiligo","volume":"141","author":"Spritz","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.09.859_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2016.09.008","article-title":"Understanding mechanisms of autoimmunity through translational research in vitiligo","volume":"43","author":"Strassner","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.jid.2026.09.859_bib33","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jid.2026.09.859_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147573","article-title":"PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders","volume":"14","author":"Topaloudi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.09.859_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/ijms24010421","article-title":"Multifaceted benefits of GDF11 treatment in spinal cord injury: In vitro and in vivo studies","volume":"24","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2026.09.859_bib36","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2026.09.859_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner's phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2026.09.859_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1182","article-title":"Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program","volume":"385","author":"Verma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jid.2026.09.859_bib39","article-title":"Innate immune activation in vitiligo: mechanisms and pathophysiological implications","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.09.859_bib40","article-title":"Causal associations between psoriasis and atopic dermatitis: A bidirectional Mendelian randomization study","volume":"20","author":"Wang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2026.09.859_bib41","article-title":"Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study","volume":"42","author":"Yang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jid.2026.09.859_bib42","article-title":"The prevalence of vitiligo: A meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26037802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26037802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:03:01Z","timestamp":1792166581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26037802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0022202X26037802"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.09.859","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo-associated variants and genes beyond immune-related loci: A genome-wide association and Mendelian randomization meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.09.859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}